Prenatal intent and postpartum receipt of long-acting reversible contraception among women receiving medication-assisted treatment for opioid use disorder

被引:21
|
作者
Kotha, Anupama [1 ]
Chen, Beatrice A. [1 ,2 ]
Lewis, Lauren [3 ]
Dunn, Shannon [2 ]
Himes, Katherine P. [1 ,2 ]
Krans, Elizabeth E. [1 ,2 ]
机构
[1] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, 300 Halket St, Pittsburgh, PA 15260 USA
[2] Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA
[3] St Francis Hosp & Med Ctr, Dept Obstet & Gynecol, 114 Woodland St, Hartford, CT 06105 USA
关键词
Opioid use disorder; Pregnancy; Postpartum contraception; Long-acting reversible contraception; INTRAUTERINE-DEVICE; PREGNANT-WOMEN; INSERTION;
D O I
10.1016/j.contraception.2018.08.008
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: Many women with opioid use disorder (OUD) do not use highly effective postpartum contraception such as long-acting reversible contraception (LARC). We evaluated factors associated with prenatal intent and postpartum receipt of LARC among women receiving medication-assisted treatment (MAT) for OUD. Study design: This was a retrospective cohort study of 791 pregnant women with OUD on MAT who delivered at an academic institution without immediate postpartum LARC services between 2009 and 2012. LARC intent was defined as a documented plan for postpartum LARC during pregnancy and LARC receipt was defined as documentation of LARC placement by 8 weeks postpartum. We organized contraceptive methods into five categories: LARC, female sterilization, short-acting methods, barrier methods and no documented method. Multivariable logistic regression identified characteristics predictive of prenatal LARC intent and postpartum LARC receipt. Results: Among 791 pregnant women with OUD on MAT, 275 (34.8%) intended to use postpartum LARC and only 237 (29.9%) attended the postpartum visit. Among 275 women with prenatal LARC intent, 124 (45.1%) attended their postpartum visit and 50 (18.2%) received a postpartum LARC. Prenatal contraceptive counseling (OR 6.67; 95% CI 3.21, 13.89) was positively associated with LARC intent. Conversely, older age (OR 0.95; 95% CI 0.91, 0.98) and private practice provider (OR 0.48; 95% CI 0.32, 0.72) were negatively associated with LARC intent. Although parity was not predictive of LARC intent, primiparous patients (CI 0.49; 95% CI 0.26, 0.97) were less likely to receive postpartum LARC. Conclusions: Discrepancies exist between prenatal intent and postpartum receipt of LARC among pregnant women with OUD on MAT. Immediate postpartum LARC services may reduce LARC access barriers. Implications: Despite prenatal interest in using LARC, most pregnant women with OUD on MAT did not receive postpartum LARC. The provision of immediate postpartum LARC services may reduce barriers to postpartum LARC receipt such as poor attendance at the postpartum visit. (C) 2018 Elsevier Inc. All rights reserved.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [1] Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder
    Matusiewicz, Alexis K.
    Melbostad, Heidi S.
    Heil, Sarah H.
    [J]. CONTRACEPTION, 2017, 96 (05) : 365 - 369
  • [2] Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont
    Rey, Catalina N.
    Badger, Gary J.
    Melbostad, Heidi S.
    Wachtel, Deborah
    Sigmon, Stacey C.
    MacAfee, Lauren K.
    Dougherty, Anne K.
    Heil, Sarah H.
    [J]. CONTRACEPTION, 2020, 101 (05) : 333 - 337
  • [3] Medicaid and receipt of interval postpartum long-acting reversible contraception
    Wilkinson, Barbara
    Ascha, Mustafa
    Verbus, Emily
    Montague, Mary
    Morris, Jane
    Mercer, Brian
    Arora, Kavita Shah
    [J]. CONTRACEPTION, 2019, 99 (01) : 32 - 35
  • [4] Medication-Assisted Treatment Use Among Pregnant Women With Opioid Use Disorder
    Krans, Elizabeth E.
    Kim, Joo Yeon
    James, Alton Everette, III
    Kelley, David
    Jarlenski, Marian P.
    [J]. OBSTETRICS AND GYNECOLOGY, 2019, 133 (05): : 943 - 951
  • [5] Group Prenatal Care for Women Receiving Medication-Assisted Treatment for Opioid Use Disorder in Pregnancy: An Interprofessional Approach
    Sutter, Mary Beth
    Watson, Hannah
    Bauers, Ariele
    Johnson, Kate
    Hatley, Mandy
    Yonke, Nicole
    Leeman, Lawrence
    [J]. JOURNAL OF MIDWIFERY & WOMENS HEALTH, 2019, 64 (02) : 217 - 224
  • [6] Trends in receipt of medication-assisted treatment for pregnant women with opioid use disorder in the United States
    MacAfee, Lauren
    Sawyer, Anne
    Terplan, Mishka
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 171 : E125 - E125
  • [7] Differences in postpartum receipt of long-acting reversible contraception by sociodemographic characteristics
    Goulding, Alison N.
    Tucker, Christine
    Verbiest, Sarah
    Bryant, Katherine
    Stuebe, Alison M.
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020, 222 (01) : S670 - S671
  • [8] BARRIERS TO RECEIVING LONG-ACTING REVERSIBLE CONTRACEPTION IN THE POSTPARTUM PERIOD
    Tang, J.
    Stuart, G.
    [J]. CONTRACEPTION, 2013, 88 (03) : 437 - 437
  • [9] Barriers to Receiving Long-acting Reversible Contraception in the Postpartum Period
    Zerden, Matthew L.
    Tang, Jennifer H.
    Stuart, Gretchen S.
    Norton, Deborah R.
    Verbiest, Sarah B.
    Brody, Seth
    [J]. WOMENS HEALTH ISSUES, 2015, 25 (06) : 616 - 621
  • [10] Postpartum Use of Long-Acting Reversible Contraception in a Military Treatment Facility
    Dahlke, Joshua D.
    Ramseyer, Abigail M.
    Terpstra, Eric R.
    Doherty, Dorota A.
    Keeler, Sean M.
    Magann, Everett F.
    [J]. JOURNAL OF WOMENS HEALTH, 2012, 21 (04) : 388 - 392